✦ LIBER ✦

Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects

✍ Scribed by Mangili, Otavio Celeste; Moron Gagliardi, Ana C.; Mangili, Leonardo Celeste; Mesquita, Carlos H.; Machado Cesar, Luiz A.; Tanaka, Akira; Schaefer, Ernst J.; Maranhão, Raul C.; Santos, Raul D.

Book ID: 122293674
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 708 KB
Volume: 233
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2013.12.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LDL concentration is correlated with the

LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease

✍ Andrei C Sposito; Raul D Santos; Whady Hueb; Laura I Ventura; Carmen C.G Vinagre 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 122 KB

The effect of hormone replacement therap

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease

✍ Eftihia Sbarouni; Zenon S. Kyriakides; Dimitrios Th Kremastinos 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Effect of simvastatin on kidney function

Effect of simvastatin on kidney function loss in patients with coronary heart disease: Findings from the Scandinavian Simvastatin Survival Study (4S)

✍ Janna Huskey; Joann Lindenfeld; Thomas Cook; Giovanni Targher; Jessica Kendrick; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Safety and Efficacy of Ezetimibe/Simvast

Safety and Efficacy of Ezetimibe/Simvastatin Combination Versus Atorvastatin Alone in Adults ≥65 Years of Age With Hypercholesterolemia and With or at Moderately High/High Risk for Coronary Heart Disease (the VYTELD Study)

✍ JoAnne M. Foody; W. Virgil Brown; Franklin Zieve; Adeniyi J. Adewale; Doreen Fla 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 954 KB

Lipid-altering efficacy of switching fro

Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease

✍ V. Barrios; N. Amabile; F. Paganelli; J-W Chen; C. Allen; A. O. Johnson-Levonas; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Comparison of the Effects of Combination

Comparison of the Effects of Combination Atorvastatin (40 mg) + Ezetimibe (10 mg) Versus Atorvastatin (40 mg) Alone on Secretory Phospholipase A2 Activity in Patients With Stable Coronary Artery Disease or Coronary Artery Disease Equivalent

✍ Mireille Azar; Emmanuel Valentin; Georges Badaoui; Roland Kassab; Antoine Sarkis 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 145 KB